Time to end the black box on antidepressants?

When the Food and Drug Administration (FDA) put a black‐box warning on antidepressants 10 years ago, it was because of a risk of suicidal thinking in young people — the very symptom for which the medications are indicated. There were immediate concerns that patients wouldn't get needed treatment, that doctors would be discouraged from prescribing, and that the worst of unintended consequences — increased suicides — would follow. [ABSTRACT FROM AUTHOR]

Copyright of Brown University Child & Adolescent Psychopharmacology Update is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)